• Senior Director, Clinical Scientist…

    Arvinas (New Haven, CT)
    …factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas ... stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer . The transaction closed in May 2024. \#TeamArvinas is made up of… more
    Arvinas (10/29/25)
    - Related Jobs

  • Co-op, Oncology -Immunology

    Arvinas (New Haven, CT)
    …of early drug discovery in a collaborative environment. This position reports to a Senior Research Scientist , Biology, Oncology and will be located at our ... of patients with locally advanced or metastatic ER+/HER2- breast cancer ; ARV-102 for the treatment of patients with neurodegenerative...headquarters in New Haven, CT. ** Principal Responsibilities** Key responsibilities of this role include, but… more
    Arvinas (11/27/25)
    - Related Jobs

  • Co-op, Platform Biology

    Arvinas (New Haven, CT)
    …of early drug discovery in a collaborative environment. This position reports to a Senior Research Scientist , Biology, Oncology and will be located at our ... of patients with locally advanced or metastatic ER+/HER2- breast cancer ; ARV-102 for the treatment of patients with neurodegenerative...headquarters in New Haven, CT. ** Principal Responsibilities** Key responsibilities of this role include, but… more
    Arvinas (11/27/25)
    - Related Jobs